Sharekhan recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 500 in its research report dated August 13, 2019.
Sharekhan's research report on Sun Pharmaceutical Industries
Strong quarterly performance; Numbers beat our as well as street’s expectations. Overall business growth guidance of double-digit teen growth with improvement in margins maintained.
We maintain our Hold rating on the stock with an upward revised PT of Rs. 500. We expect the company to report a sales and profit CAGR of 20% and 38%, respectively, over FY2019-FY2021E.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.Subscribe to Moneycontrol Pro and gain access to curated markets data, trading recommendations, equity analysis, investment ideas, insights from market gurus and much more. Get Moneycontrol PRO for 1 year at price of 3 months at 289. Use code FREEDOM.